Wednesday, March 22, 2023 | Back issues
Courthouse News Service Courthouse News Service

Prescription Drug

CHICAGO - Fifteen complaints claim that Novartis Pharmaceuticals failed to warn people who took Tegretol, an anti-convulsant/epilepsy drug, that they could develop Stevens-Johnson syndrome, a skin disease with "potentially fatal adverse reactions."

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.